Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 95DB2 | — |
patient received today an expired dose of Havrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 82-year-old female patient who received HAV (Havrix) (batch number 95DB2, expiry date 13-DEC-2024) for prophylaxis. On 27-JAN-2025, the patient received Havrix. On 27-JAN-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: patient received today an expired dose of Havrix). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 27-JAN-2025 Other HCP reported that a patient received an expired dose of Havrix, which led to expired vaccine used. The vaccine expired on 13th December, 2024. The HCP asked if the dose is considered valid.